The γ/ε-secretase-derived APP intracellular domain fragments regulate p53

Current Alzheimer Research

Volumn 4, Issue 4, 2007, Pages 423-426

  Checler, Frédéric ^a   Sunyach, Claire ^a   Pardossi Piquard, Raphaelle ^a   Sévalle, Jean ^a   Vincent, Bruno ^a   Kawarai, Toshitaka ^b   Girardot, Nadège ^c   St George Hyslop, Peter ^b   Da Costa, Cristine Alves ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITY OF TORONTO   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PRECURSOR LIKE PROTEIN 2; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CASPASE 3; ENZYME; EPSILON SECRETASE; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; MESSENGER RNA; PRESENILIN 1; PRESENILIN 2; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; PEPTIDE; SECRETASE;

ALZHEIMER DISEASE; BRAIN; CELL DEATH; CELL STRAIN HEK293; CONFERENCE PAPER; ENZYME ACTIVATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; PROTEIN TERTIARY STRUCTURE; REVIEW;

AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548699654     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507781788945     Document Type: Conference Paper

References (24)

1. de la Monte S, Sohn YK, Ganju YK and Wands JR. p53- and CD95-associated apoptosis in neurodegenerative diseases, Lab Invest 78 : 401-411 (1998).
2. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. Changes of p53 in the brains patients with Alzheimer disease, Biochem Biophys Res Comm 232 : 418-421 (1997).
3. Garcia-Ospina GP, Ginenez-del Rio M, Lopera F and Velez-Pardo C. Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor κB, p53 and Par-4 transcription factors in Alzheimer's disease, Rev Neurol 36 :1004-1010 (2003).
4. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K, et al, Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease, FASEB J 19 : 255-257 (2005).
5. Checler F. Presenilins: multifunctional proteins involved in Alzheimer's disease pathology, Iubmb LIFE 48 : 33-39 (1999).
6. De Strooper, B. Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex, Neuron 38: 9-12 (2003).
7. Haass C. Take five-BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation, EMBO J 23 : 483-488 (2004).
8. Bursztajn S, DeSouza R, McPhie DL, Berman SA, Shioi J, Robakis NK, et al. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer's disease mutant does not enhance apoptosis., J Neurosci 18 : 9790-9799 (1998).
9. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E, Sunderland T, et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation., Science 274 : 1710-1713 (1996).
10. Araki W. Presenilins and cell death, Curr Topics in Biochem Res 3: 157-162 (2000).
11. Alves da Costa C, Paitel E, Mattson MP, Amson R, Telerman A, Ancolio K, et al. Wild-type and mutated presenilin-2 trigger p53-dependent apoptosis and down-regulate presenilin-1 expression in HEK293 human cells and in murine neurons, Proc Natl Acad Sci USA 99: 4043-4048 (2002).
12. Alves da Costa C, Mattson M, Ancolio K and Checler F. The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart, J Biol Chem 278 : 12064-12069 (2003).
13. Cao X and Südhof TC. A transcriptively active complex of APP with Fe65 and histone acetyltransferase tip60, Science 293 : 115-120 (2001).
14. Gao Y and Pimplikar SW. The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus, Proc Natl Acad Sci USA 98 : 14979-14984 (2001).
15. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK and Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein, Cell 110 : 55-67 (2002).
16. Kim HS, Kim EM, Lee JP, Park CH, Kim SJ, Seo JH, et al. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression, FASEB J 17 : 1951-1953.
17. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor., J Cell Sci 117 : 4435-4448 (2004).
18. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP, Neuron 46 : 541-554 (2005).
19. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Boyer N, et al. Presenilin-dependent γ-secretase-mediated control of p53-associated cell death in Alzheimer's disease, J Neurosci 26 : 6377-6385 (2006).
20. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardio MJ, Schettini G, et al. Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer's amyloid β protein precursor, J Alzheimer's Disease 2 ; 289-301 (2000).
21. Kang DE, Yoon IS, Repetto E, Busse T, Yermian N, Ie L and Koo EH. Presenilins mediate PI3K/AKT and ERK activation via select signaling receptors: selectivity of PS2 in PDGF signaling, J Biol Chem 280 : 31537-31547 (2005).
22. Edbauer D, Willem M, Lammich S, Steiner H and Haass C, Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277 :13389-13393 (2002).
23. Marambaud P, Ancolio K, Lopez-Perez E and Checler F. Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and trigger increased Aβ42 secretion by human cells., Mol Medicine 4 : 147-157 (1998).
24. Pardossi-Piquard R, Dunys J, Yu G, St George-Hyslop P, Alves da Costa C and Checler F. Neprilysin activity and expression are controlled by nicastrin, J Neurochem 97 :1052-1056 (2006).